The Journey Through the Pathogenesis and Treatment of Venous Thromboembolism in Inflammatory Bowel Diseases: A Narrative Review

被引:14
作者
Boccatonda, Andrea [1 ,4 ]
Balletta, Marco [2 ]
Vicari, Susanna [1 ]
Hoxha, Ariela [3 ]
Simioni, Paolo [3 ]
Campello, Elena [3 ]
机构
[1] Bentivoglio Hosp, AUSL Bologna, Dept Internal Med, Bologna, Italy
[2] Bologna Univ, Dept Internal Med, Bologna, Italy
[3] Padova Univ Hosp, Dept Med DIMED, Hemorrhag & Thrombot Dis Unit, Padua, Italy
[4] Bentivoglio Hosp, Dept Internal Med, AUSL Bologna, Via Marconi Bentivoglio Hosp 35, I-40100 Bentivoglio, BO, Italy
关键词
immunothrombosis; hypercoagulability; pulmonary embolism; thromboinflammation; venous thrombosis; VON-WILLEBRAND-FACTOR; FACTOR-V-LEIDEN; RISK-FACTORS; PROTEIN-C; EXTRAINTESTINAL MANIFESTATIONS; ACTIVATED RECEPTORS; THROMBIN GENERATION; ENDOTHELIAL-CELLS; VEIN-THROMBOSIS; CROHNS-DISEASE;
D O I
10.1055/s-0042-1758869
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the gastrointestinal tract including Crohn's disease and ulcerative colitis, which may result in several extraintestinal complications (similar to 20-30% of cases), such as increased risk of venous thromboembolism (VTE). The main pathophysiological mechanism of VTE is an inflammation-induced hypercoagulable state, and recent data have shown that endothelial dysregulation due to gut and systemic inflammation may also lead to a prothrombotic state. Several prothrombotic alterations have been described, such as the activation of the coagulation system, platelet abnormalities, and dysregulation of fibrinolysis. Furthermore, the dysregulation of the gut microbiome seems to play a vital role in increasing systemic inflammation and thus inducing a procoagulant state. Our review aims to examine the main correlations between IBD and VTE, the underlying pathophysiology, and current therapeutic options.
引用
收藏
页码:744 / 755
页数:12
相关论文
共 111 条
[1]   Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present) [J].
Al-Horani, Rami A. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2020, 30 (01) :39-55
[2]   Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis [J].
Alhassan, N. ;
Trepanier, M. ;
Sabapathy, C. ;
Chaudhury, P. ;
Liberman, A. S. ;
Charlebois, P. ;
Stein, B. L. ;
Lee, L. .
TECHNIQUES IN COLOPROCTOLOGY, 2018, 22 (12) :955-964
[3]   Continuous Active State of Coagulation System in Patients With Nonthrombotic Inflammatory Bowel Disease [J].
Alkim, Huseyin ;
Ayaz, Selime ;
Alkim, Canan ;
Ulker, Aysel ;
Sahin, Burhan .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2011, 17 (06) :600-604
[4]   Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases [J].
Ananthakrishnan, Ashwin N. ;
Cagan, Andrew ;
Gainer, Vivian S. ;
Cheng, Su-Chun ;
Cai, Tianxi ;
Scoville, Elizabeth ;
Konijeti, Gauree G. ;
Szolovits, Peter ;
Shaw, Stanley Y. ;
Churchill, Susanne ;
Karlson, Elizabeth W. ;
Murphy, Shawn N. ;
Kohane, Isaac ;
Liao, Katherine P. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (11) :1905-1910
[5]   Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis [J].
Anderson, Alyce ;
Click, Benjamin ;
Ramos-Rivers, Claudia ;
Cheng, Debbie ;
Babichenko, Dmitriy ;
Koutroubakis, Ioannis E. ;
Hashash, Jana G. ;
Schwartz, Marc ;
Swoger, Jason ;
Barrie, Arthur M., III ;
Dunn, Michael A. ;
Regueiro, Miguel ;
Binion, David G. .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (12) :2180-2188
[6]   The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study [J].
Ando, Katsuyoshi ;
Fujiya, Mikihiro ;
Nomura, Yoshiki ;
Inaba, Yuhei ;
Sugiyama, Yuuya ;
Iwama, Takuya ;
Ijiri, Masami ;
Takahashi, Keitaro ;
Tanaka, Kazuyuki ;
Sakatani, Aki ;
Ueno, Nobuhiro ;
Kashima, Shin ;
Moriichi, Kentaro ;
Mizukami, Yusuke ;
Okumura, Toshikatsu .
INTESTINAL RESEARCH, 2018, 16 (03) :416-425
[7]   Endoscopic activity, tissue factor and Crohn's disease: findings in clinical remission patients [J].
Andrade, Adriana Ribas ;
Flores da Rocha, Tania Rubia ;
Ortiz-Agostinho, Carmen Lucia ;
Nishitokukado, Ieda ;
Carlos, Alexandre Sousa ;
Cardoso de Azevedo, Matheus Freitas ;
Hashimoto, Claudio Lioshi ;
Moura Cintra Damiao, Aderson Omar ;
Carrilho, Flair Jose ;
D'Amico, Elbio ;
Sipahi, Aytan Miranda ;
de Arruda Leite, Andre Zonetti .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
[8]   Risk of Venous Thromboembolism in Patients with Inflammatory Bowel Disease Extends beyond Hospitalization [J].
Bafford, Andrea C. ;
Cross, Raymond K. .
INFLAMMATORY BOWEL DISEASES, 2020, 26 (11) :1769-1770
[9]   Extended Venous Thromboembolism Prophylaxis After Elective Surgery for IBD Patients: Nomogram-Based Risk Assessment and Prediction from Nationwide Cohort [J].
Benlice, Cigdem ;
Holubar, Stefan D. ;
Gorgun, Emre ;
Stocchi, Luca ;
Lipman, Jeremy M. ;
Kalady, Matthew F. ;
Champagne, Bradley J. ;
Steele, Scott R. .
DISEASES OF THE COLON & RECTUM, 2018, 61 (10) :1170-1179
[10]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430